Evidence map›Paper›PMID 40466213›Full record

ReviewCurrent opinion in cell biology2025

RAS/ERK signaling and PLK1: Coordinating developmental regulation and disease mechanisms.

Han Bit Baek, Swathi Arur

Abstract readReview
In one paragraph

Review in Current opinion in cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Han Bit BaekGenetics and Epigenetics Program, University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Swathi ArurGenetics and Epigenetics Program, University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: SArur@mdanderson.org.

Funding

How Post-Translational Codes and Small RNA Pathways Shape Developmental OutcomesR35GM140933 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Swathi Arur · 2021 to 2026
$2.5M
ERK mediated regulation of RbAp46/48 during female germ cell developmentR01HD101269 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ARUR, SWATHI · 2020 to 2024
$1.6M
NICHD NIH HHS R01 HD101269NIGMS NIH HHS R35 GM140933
6 · The paper itself

Abstract

The RAS/ERK signaling pathway is a critical regulator of cellular processes such as proliferation, differentiation, and survival, core mechanisms that drive development. Dysregulation of RAS/ERK signaling is implicated in developmental disorders, including RASopathies, as well as in various cancers. Polo-like kinase 1 (PLK1) is a crucial orchestrator of both meiotic and mitotic cell cycle and plays an equally important role in development. Notably, abnormal ERK signaling can produce phenotypes that closely resemble those caused by PLK1 deficiency, suggesting a functional intersection between these pathways. In this review, we explore the emerging links between RAS/ERK and PLK1 signaling during development and highlight the broad range of biological processes potentially governed by their interaction.

Indexed as

Cell Cycle ProteinsMAP Kinase Signaling SystemProtein Serine-Threonine KinasesProto-Oncogene Proteinsras ProteinsAnimalsHumansNeoplasmsPolo-Like Kinase 1Signal TransductionCell Cycle ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene Proteinsras Proteins

Identifiers

PMID40466213
PMCPMC13431139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.